BLAINTRAMUSCULARINJECTABLE
Approved
Jun 2021
Lifecycle
Peak
Competitive Pressure
30/100
Mechanism of Action
(recombinant)-rywn is an enzyme that catalyzes the conversion of the amino acid L-asparagine into aspartic acid and ammonia. The pharmacological effect of RYLAZE is based on the killing of leukemic cells due to depletion of plasma asparagine. Leukemic cells with low expression of asparagine…
Pharmacologic Class:
Asparagine-specific Enzyme